1
|
Aljahdali A, Airina RKRI, Velazquez MA, Sheth B, Wallen K, Osmond C, Watkins AJ, Eckert JJ, Smyth NR, Fleming TP. The duration of embryo culture after mouse IVF differentially affects cardiovascular and metabolic health in male offspring. Hum Reprod 2021; 35:2497-2514. [PMID: 33020802 PMCID: PMC7603862 DOI: 10.1093/humrep/deaa205] [Citation(s) in RCA: 22] [Impact Index Per Article: 7.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/12/2020] [Revised: 07/14/2020] [Indexed: 12/26/2022] Open
Abstract
STUDY QUESTION Do the long-term health outcomes following IVF differ depending upon the duration of embryo culture before transfer? SUMMARY ANSWER Using a mouse model, we demonstrate that in male but not female offspring, adverse cardiovascular (CV) health was more likely with prolonged culture to the blastocyst stage, but metabolic dysfunction was more likely if embryo transfer (ET) occurred at the early cleavage stage. WHAT IS KNOWN ALREADY ART associate with increased risk of adverse CV and metabolic health in offspring, and these findings have been confirmed in animal models in the absence of parental infertility issues. It is unclear which specific ART treatments may cause these risks. There is increasing use of blastocyst, versus cleavage-stage, transfer in clinical ART which does not appear to impair perinatal health of children born, but the longer-term health implications are unknown. STUDY DESIGN, SIZE, DURATION Five mouse groups were generated comprising: (i) natural mating (NM)—naturally mated, non-superovulated and undisturbed gestation; (ii) IV-ET-2Cell—in-vivo derived two-cell embryos collected from superovulated mothers, with immediate ET to recipients; (iii) IVF-ET-2Cell—IVF generated embryos, from oocytes from superovulated mothers, cultured to the two-cell stage before ET to recipients; (iv) IV-ET-BL—in-vivo derived blastocysts collected from superovulated mothers, with immediate ET to recipients; (v) IVF-ET-BL—IVF generated embryos, from oocytes from superovulated mothers, cultured to the blastocyst stage before ET to recipients. Both male and female offspring were analysed for growth, CV and metabolic markers of health. There were 8–13 litters generated for each group for analyses; postnatal data were analysed by multilevel random effects regression to take account of between-mother and within-mother variation and litter size. PARTICIPANTS/MATERIALS, SETTINGS, METHODS C57/BL6 female mice (3–4 weeks old) were used for oocyte production; CBA males for sperm with human tubal fluid medium were used for IVF. Embryos were transferred (ET) to MF1 pseudo-pregnant recipients at the two-cell stage or cultured in synthetic oviductal medium enriched with potassium medium to the blastocyst stage before ET. Control in-vivo embryos from C57BL6 × CBA matings were collected and immediately transferred at the two-cell or blastocyst stage. Postnatal assays included growth rate up to 27 weeks; systolic blood pressure (SBP) at 9, 15 and 21 weeks; lung and serum angiotensin-converting enzyme (ACE) activity at time of cull (27 weeks); glucose tolerance test (GTT; 27 weeks); basal glucose and insulin levels (27 weeks); and lipid accumulation in liver cryosections using Oil Red O imaging (27 weeks). MAIN RESULTS AND THE ROLE OF CHANCE Blastocysts formed by IVF developed at a slower rate and comprised fewer cells that in-vivo generated blastocysts without culture (P < 0.05). Postnatal growth rate was increased in all four experimental treatments compared with NM group (P < 0.05). SBP, serum and lung ACE and heart/body weight were higher in IVF-ET-BL versus IVF-ET-2Cell males (P < 0.05) and higher than in other treatment groups, with SBP and lung ACE positively correlated (P < 0.05). Glucose handling (GTT AUC) was poorer and basal insulin levels were higher in IVF-ET-2Cell males than in IVF-ET-BL (P < 0.05) with the glucose:insulin ratio more negatively correlated with body weight in IVF-ET-2Cell males than in other groups. Liver/body weight and liver lipid droplet diameter and density in IVF-ET-2Cell males were higher than in IVF-ET-BL males (P < 0.05). IVF groups had poorer health characteristics than their in-vivo control groups, indicating that outcomes were not caused specifically by background techniques (superovulation, ET). No consistent health effects from duration of culture were identified in female offspring. LARGE SCALE DATA N/A. LIMITATIONS, REASONS FOR CAUTION Results from experimental animal models cannot be extrapolated to humans. Nevertheless, they are valuable to develop conceptual models, in this case, in the absence of confounding parental infertility, in assessing the safety of ART manipulations. WIDER IMPLICATIONS OF THE FINDINGS The study indicates that longer duration of embryo culture after IVF up to blastocyst before ET leads to increased dysfunction of CV health in males compared with IVF and shorter cleavage-stage ET. However, the metabolic health of male offspring was poorer after shorter versus longer culture duration. This distinction indicates that the origin of CV and metabolic health phenotypes after ART may be different. The poorer metabolic health of males after cleavage-stage ET coincides with embryonic genome activation occurring at the time of ET. STUDY FUNDING/COMPETING INTEREST(S) This work was supported through the European Union FP7-CP-FP Epihealth programme (278418) and FP7-PEOPLE-2012-ITN EpiHealthNet programme (317146) to T.P.F., the Biotechnology and Biological Sciences Research Council (BBSRC) (BB/F007450/1) to T.P.F., and the Saudi government, University of Jeddah and King Abdulaziz University to A.A. The authors have no conflicts of interest to declare.
Collapse
Affiliation(s)
- Anan Aljahdali
- School of Biological Sciences, University of Southampton, Southampton General Hospital, Southampton SO16 6YD, UK.,University of Jeddah, Jeddah, Saudi Arabia
| | - R K Raja Ili Airina
- School of Biological Sciences, University of Southampton, Southampton General Hospital, Southampton SO16 6YD, UK
| | - Miguel A Velazquez
- School of Natural and Environmental Sciences, Newcastle University, Newcastle Upon Tyne NE1 7RU, UK
| | - Bhavwanti Sheth
- School of Biological Sciences, University of Southampton, Southampton General Hospital, Southampton SO16 6YD, UK
| | - Katrina Wallen
- School of Biological Sciences, University of Southampton, Southampton General Hospital, Southampton SO16 6YD, UK
| | - Clive Osmond
- MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton SO16 6YD, UK
| | - Adam J Watkins
- Division of Child Health, Obstetrics and Gynaecology, Faculty of Medicine, University of Nottingham, Nottingham NG7 2UH, UK
| | - Judith J Eckert
- Human Development and Health, Faculty of Medicine, University of Southampton, Southampton General Hospital, Southampton SO16 6YD, UK
| | - Neil R Smyth
- School of Biological Sciences, University of Southampton, Southampton General Hospital, Southampton SO16 6YD, UK
| | - Tom P Fleming
- School of Biological Sciences, University of Southampton, Southampton General Hospital, Southampton SO16 6YD, UK
| |
Collapse
|
2
|
Yang N, Sun L, Tan J. Theme trends and knowledge structure of assisted reproductive technology and birth defects: A quantitative and co-word analysis. J Obstet Gynaecol Res 2021; 47:1780-1788. [PMID: 33783096 DOI: 10.1111/jog.14702] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/28/2020] [Revised: 12/02/2020] [Accepted: 01/29/2021] [Indexed: 12/22/2022]
Abstract
AIM The main purpose of our study is to determine the current research status of assisted reproductive technology (ART) and birth defects by means of co-word analysis, to explore the hot spots and weak points of current research, and to provide ideas and opinions for follow-up researchers. METHODS The PubMed database was used to investigate the knowledge structures of the applied words ART and birth defects. The published literature was searched until December 31, 2018. The extracted MeSH terms were quantified using the Bibliographic Item Co-Occurrence Matrix Builder and the high-frequency MeSH terms were determined. According to the MeSH term-source article matrix, hierarchical cluster analysis was performed using SPSS 19.0. The high frequency MeSH term co-occurrence matrix was constructed to support strategic diagram and social network analysis (SNA). RESULTS According to the search strategy, 1635 papers were included. Of all the extracted MeSH terms, 105 high frequency MeSH terms were identified and the hotspots were classified into nine categories. In the strategic diagram, research on the effects of prenatal diagnosis methods and ART on the development of offspring has been well developed. In contrast, research on reproductive ethics, epigenetics, and epidemiology is relatively immature, indicating the need for future research. For SNA results, the position status of each component is described by the center value. CONCLUSIONS By providing a quantitative bibliometric study, it can help with the overall command of the latest topic and guide researchers in their new projects.
Collapse
Affiliation(s)
- Na Yang
- Department of Obstetrics and Gynaecology, Assisted Reproduction Centre, Shengjing Hospital Affiliated to China Medical University, Shenyang, China.,Gynecology Clinic, Shenyang Jianghua Hospital, Shenyang, China
| | - Li Sun
- Department of Reproductive Medical Center, Guangdong Women and Children Hospital, Guangzhou, China
| | - Jichun Tan
- Department of Obstetrics and Gynaecology, Assisted Reproduction Centre, Shengjing Hospital Affiliated to China Medical University, Shenyang, China.,Key Laboratory of Reproductive Dysfunction Diseases and Fertility Remodelling of Liaoning Province, Shengjing Hospital Affiliated to China Medical University, Shenyang, China
| |
Collapse
|
3
|
Heber MF, Ptak GE. The effects of assisted reproduction technologies on metabolic health and disease†. Biol Reprod 2020; 104:734-744. [PMID: 33330924 PMCID: PMC8023432 DOI: 10.1093/biolre/ioaa224] [Citation(s) in RCA: 20] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/03/2020] [Revised: 11/12/2020] [Accepted: 12/04/2020] [Indexed: 12/17/2022] Open
Abstract
The increasing prevalence of metabolic diseases places a substantial burden on human health throughout the world. It is believed that predisposition to metabolic disease starts early in life, a period of great susceptibility to epigenetic reprogramming due to environmental insults. Assisted reproductive technologies (ART), i.e., treatments for infertility, may affect embryo development, resulting in multiple adverse health outcomes in postnatal life. The most frequently observed alteration in ART pregnancies is impaired placental nutrient transfer. Moreover, consequent intrauterine growth restriction and low birth weight followed by catch-up growth can all predict future obesity, insulin resistance, and chronic metabolic diseases. In this review, we have focused on evidence of adverse metabolic alterations associated with ART, which can contribute to the development of chronic adult-onset diseases, such as metabolic syndrome, type 2 diabetes, and cardiovascular disease. Due to high phenotypic plasticity, ART pregnancies can produce both offspring with adverse health outcomes, as well as healthy individuals. We further discuss the sex-specific and age-dependent metabolic alterations reflected in ART offspring, and how the degree of interference of a given ART procedure (from mild to more severe manipulation of the egg) affects the occurrence and degree of offspring alterations. Over the last few years, studies have reported signs of cardiometabolic alterations in ART offspring that are detectable at a young age but that do not appear to constitute a high risk of disease and morbidity per se. These abnormal phenotypes could be early indicators of the development of chronic diseases, including metabolic syndrome, in adulthood. The early detection of metabolic alterations could contribute to preventing the onset of disease in adulthood. Such early interventions may counteract the risk factors and improve the long-term health of the individual.
Collapse
Affiliation(s)
| | - Grażyna Ewa Ptak
- Malopolska Centre of Biotechnology, Jagiellonian University, Krakow, Poland.,Faculty of Biosciences, University of Teramo, Teramo, Italy
| |
Collapse
|
4
|
Manrique-Acevedo C, Ramirez-Perez FI, Padilla J, Vieira-Potter VJ, Aroor AR, Barron BJ, Chen D, Haertling D, Declue C, Sowers JR, Martinez-Lemus LA. Absence of Endothelial ERα Results in Arterial Remodeling and Decreased Stiffness in Western Diet-Fed Male Mice. Endocrinology 2017; 158:1875-1885. [PMID: 28430983 PMCID: PMC5460939 DOI: 10.1210/en.2016-1831] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/09/2016] [Accepted: 04/13/2017] [Indexed: 01/16/2023]
Abstract
The role of estrogen receptor-α (ERα) signaling in the vasculature of females has been described under different experimental conditions and our group recently reported that lack of endothelial cell (EC) ERα in female mice fed a Western diet (WD) results in amelioration of vascular stiffness. Conversely, the role of ERα in the male vasculature in this setting has not been explored. In conditions of overnutrition and insulin resistance, augmented arterial stiffness, endothelial dysfunction, and arterial remodeling contribute to the development of cardiovascular disease. Here, we used a rodent model of decreased ERα expression in ECs [endothelial cell estrogen receptor-α knockout (EC-ERαKO)] to test the hypothesis that, similar to our findings in females, loss of ERα signaling in the endothelium of insulin-resistant males would result in decreased arterial stiffness. EC-ERαKO male mice and same-sex littermates were fed a WD (high in fructose and fat) for 20 weeks and then assessed for vascular function and stiffness. EC-ERαKO mice were heavier than littermates but exhibited decreased vascular stiffness without differences in endothelial-dependent vasodilatory responses. Mesenteric arteries from EC-ERαKO mice had significantly increased diameters, wall cross-sectional areas, and mean wall thicknesses, indicative of outward hypertrophic remodeling. This remodeling paralleled an increased vessel wall content of collagen and elastin, inhibition of matrix metalloproteinase activation and a decrease of the incremental modulus of elasticity. In addition, internal elastic lamina fenestrae were more abundant in the EC-ERαKO mice. In conclusion, loss of endothelial ERα reduces vascular stiffness in male mice fed a WD with an associated outward hypertrophic remodeling of resistance arteries.
Collapse
Affiliation(s)
- Camila Manrique-Acevedo
- Department of Medicine, Division of Endocrinology, University of Missouri, Columbia, Missouri 65212
| | - Francisco I Ramirez-Perez
- Dalton Cardiovascular Research Center, University of Missouri, Columbia, Missouri 65211
- Department of Biological Engineering, University of Missouri, Columbia, Missouri 65211
| | - Jaume Padilla
- Dalton Cardiovascular Research Center, University of Missouri, Columbia, Missouri 65211
- Department of Nutrition and Exercise Physiology, University of Missouri, Columbia, Missouri 65211
- Department of Child Health, University of Missouri, Columbia, Missouri 65212
| | - Victoria J Vieira-Potter
- Department of Nutrition and Exercise Physiology, University of Missouri, Columbia, Missouri 65211
| | - Annayya R Aroor
- Department of Medicine, Division of Endocrinology, University of Missouri, Columbia, Missouri 65212
| | - Brady J Barron
- Department of Medicine, Division of Endocrinology, University of Missouri, Columbia, Missouri 65212
| | - Dongqing Chen
- Department of Medicine, Division of Endocrinology, University of Missouri, Columbia, Missouri 65212
| | - Dominic Haertling
- School of Medicine, University of Missouri, Columbia, Missouri 65212
| | - Cory Declue
- School of Medicine, University of Missouri, Columbia, Missouri 65212
| | - James R Sowers
- Department of Medicine, Division of Endocrinology, University of Missouri, Columbia, Missouri 65212
- Dalton Cardiovascular Research Center, University of Missouri, Columbia, Missouri 65211
- Department of Medical Pharmacology and Physiology, University of Missouri, Columbia, Missouri 65212
- Research Service, Harry S. Truman Memorial Veterans Hospital, Columbia, Missouri 65201
| | - Luis A Martinez-Lemus
- Dalton Cardiovascular Research Center, University of Missouri, Columbia, Missouri 65211
- Department of Biological Engineering, University of Missouri, Columbia, Missouri 65211
- Department of Medical Pharmacology and Physiology, University of Missouri, Columbia, Missouri 65212
| |
Collapse
|
5
|
Vrooman LA, Bartolomei MS. Can assisted reproductive technologies cause adult-onset disease? Evidence from human and mouse. Reprod Toxicol 2016; 68:72-84. [PMID: 27474254 DOI: 10.1016/j.reprotox.2016.07.015] [Citation(s) in RCA: 57] [Impact Index Per Article: 7.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2016] [Revised: 07/15/2016] [Accepted: 07/22/2016] [Indexed: 12/27/2022]
Abstract
Millions of children have been born worldwide though assisted reproductive technologies (ART). Consistent with the Developmental Origins of Health and Disease hypothesis, there is concern that ART can induce adverse effects, especially because procedures coincide with epigenetic reprogramming events. Although the majority of studies investigating the effects of ART have focused on perinatal outcomes, more recent studies demonstrate that ART-conceived children may be at increased risk for postnatal effects. Here, we present the current epidemiological evidence that ART-conceived children have detectable differences in blood pressure, body composition, and glucose homeostasis. Similar effects are observed in the ART mouse model, which have no underlying infertility, suggesting that cardiometabolic effects are likely caused by ART procedures and not due to reasons related to infertility. We propose that the mouse system can, consequently, be used to adequately study, modify, and improve outcomes for ART children.
Collapse
Affiliation(s)
- Lisa A Vrooman
- Department of Cell and Developmental Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
| | - Marisa S Bartolomei
- Department of Cell and Developmental Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
| |
Collapse
|
6
|
Pennington KA, Ramirez-Perez FI, Pollock KE, Talton OO, Foote CA, Reyes-Aldasoro CC, Wu HH, Ji T, Martinez-Lemus LA, Schulz LC. Maternal Hyperleptinemia Is Associated with Male Offspring's Altered Vascular Function and Structure in Mice. PLoS One 2016; 11:e0155377. [PMID: 27187080 PMCID: PMC4871503 DOI: 10.1371/journal.pone.0155377] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/03/2016] [Accepted: 04/27/2016] [Indexed: 12/27/2022] Open
Abstract
Children of mothers with gestational diabetes have greater risk of developing hypertension but little is known about the mechanisms by which this occurs. The objective of this study was to test the hypothesis that high maternal concentrations of leptin during pregnancy, which are present in mothers with gestational diabetes and/or obesity, alter blood pressure, vascular structure and vascular function in offspring. Wildtype (WT) offspring of hyperleptinemic, normoglycemic, Leprdb/+ dams were compared to genotype matched offspring of WT-control dams. Vascular function was assessed in male offspring at 6, and at 31 weeks of age after half the offspring had been fed a high fat, high sucrose diet (HFD) for 6 weeks. Blood pressure was increased by HFD but not affected by maternal hyperleptinemia. On a standard diet, offspring of hyperleptinemic dams had outwardly remodeled mesenteric arteries and an enhanced vasodilatory response to insulin. In offspring of WT but not Leprdb/+ dams, HFD induced vessel hypertrophy and enhanced vasodilatory responses to acetylcholine, while HFD reduced insulin responsiveness in offspring of hyperleptinemic dams. Offspring of hyperleptinemic dams had stiffer arteries regardless of diet. Therefore, while maternal hyperleptinemia was largely beneficial to offspring vascular health under a standard diet, it had detrimental effects in offspring fed HFD. These results suggest that circulating maternal leptin concentrations may interact with other factors in the pre- and post -natal environments to contribute to altered vascular function in offspring of diabetic pregnancies.
Collapse
Affiliation(s)
- Kathleen A. Pennington
- Department of Obstetrics, Gynecology, and Women’s Health, University of Missouri, Columbia, Missouri, United States of America
| | - Francisco I. Ramirez-Perez
- Dalton Cardiovascular Research Center, University of Missouri, Columbia, Missouri, United States of America
- Department of Biological Engineering, University of Missouri, Columbia, Missouri, United States of America
| | - Kelly E. Pollock
- Department of Obstetrics, Gynecology, and Women’s Health, University of Missouri, Columbia, Missouri, United States of America
| | - Omonseigho O. Talton
- Department of Obstetrics, Gynecology, and Women’s Health, University of Missouri, Columbia, Missouri, United States of America
- Division of Biological Sciences, University of Missouri, Columbia, Missouri, United States of America
| | - Christopher A. Foote
- Dalton Cardiovascular Research Center, University of Missouri, Columbia, Missouri, United States of America
| | | | - Ho-Hsiang Wu
- Department of Statistics, University of Missouri, Columbia, Missouri, United States of America
| | - Tieming Ji
- Department of Statistics, University of Missouri, Columbia, Missouri, United States of America
| | - Luis A. Martinez-Lemus
- Dalton Cardiovascular Research Center, University of Missouri, Columbia, Missouri, United States of America
- Department of Biological Engineering, University of Missouri, Columbia, Missouri, United States of America
- Department of Medical Pharmacology and Physiology, University of Missouri, Columbia, Missouri, United States of America
- * E-mail: (LAM); (LCS)
| | - Laura C. Schulz
- Department of Obstetrics, Gynecology, and Women’s Health, University of Missouri, Columbia, Missouri, United States of America
- Division of Biological Sciences, University of Missouri, Columbia, Missouri, United States of America
- * E-mail: (LAM); (LCS)
| |
Collapse
|
7
|
Manrique C, Lastra G, Ramirez-Perez FI, Haertling D, DeMarco VG, Aroor AR, Jia G, Chen D, Barron BJ, Garro M, Padilla J, Martinez-Lemus LA, Sowers JR. Endothelial Estrogen Receptor-α Does Not Protect Against Vascular Stiffness Induced by Western Diet in Female Mice. Endocrinology 2016; 157:1590-600. [PMID: 26872089 PMCID: PMC4816732 DOI: 10.1210/en.2015-1681] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
Consumption of a diet high in fat and refined carbohydrates (Western diet [WD]) is associated with obesity and insulin resistance, both major risk factors for cardiovascular disease (CVD). In women, obesity and insulin resistance abrogate the protection against CVD likely afforded by estrogen signaling through estrogen receptor (ER)α. Indeed, WD in females results in increased vascular stiffness, which is independently associated with CVD. We tested the hypothesis that loss of ERα signaling in the endothelium exacerbates WD-induced vascular stiffening in female mice. We used a novel model of endothelial cell (EC)-specific ERα knockout (EC-ERαKO), obtained after sequential crossing of the ERα double floxed mice and VE-Cadherin Cre-recombinase mice. Ten-week-old females, EC-ERαKO and aged-matched genopairs were fed either a regular chow diet (control diet) or WD for 8 weeks. Vascular stiffness was measured in vivo by pulse wave velocity and ex vivo in aortic explants by atomic force microscopy. In addition, vascular reactivity was assessed in isolated aortic rings. Initial characterization of the model fed a control diet did not reveal changes in whole-body insulin sensitivity, aortic vasoreactivity, or vascular stiffness in the EC-ERαKO mice. Interestingly, ablation of ERα in ECs reduced WD-induced vascular stiffness and improved endothelial-dependent dilation. In the setting of a WD, endothelial ERα signaling contributes to vascular stiffening in females. The precise mechanisms underlying the detrimental effects of endothelial ERα in the setting of a WD remain to be elucidated.
Collapse
Affiliation(s)
- Camila Manrique
- Division of Endocrinology, Diabetes and Metabolism (V.G.D., G.L., G.J., A.R.A., C.M., J.R.S., D.H., D.C., B.J.B., M.G.), Department of Medicine, University of Missouri Columbia School of Medicine, Columbia, Missouri 65212; Department of Medical Pharmacology and Physiology (65212) (V.G.D., F.I.R.-P., L.A.M.-L., J.R.S.) and Research Service (V.G.D., J.R.S.), Harry S Truman Memorial Veterans Hospital, Columbia, Missouri 65201; Dalton Cardiovascular Research Center (F.I.R.-P., L.A.M.-L., J.P.), University of Missouri, Columbia, Missouri 65201; Department of Nutrition and Exercise Physiology (J.P.), University of Missouri, Columbia, Missouri 65211; and Departments of Child Health (65201) (J.P.) and Biological Engineering (L.A.M.-L., F.I.R.-P.), University of Missouri, Columbia, Missouri 65211
| | - Guido Lastra
- Division of Endocrinology, Diabetes and Metabolism (V.G.D., G.L., G.J., A.R.A., C.M., J.R.S., D.H., D.C., B.J.B., M.G.), Department of Medicine, University of Missouri Columbia School of Medicine, Columbia, Missouri 65212; Department of Medical Pharmacology and Physiology (65212) (V.G.D., F.I.R.-P., L.A.M.-L., J.R.S.) and Research Service (V.G.D., J.R.S.), Harry S Truman Memorial Veterans Hospital, Columbia, Missouri 65201; Dalton Cardiovascular Research Center (F.I.R.-P., L.A.M.-L., J.P.), University of Missouri, Columbia, Missouri 65201; Department of Nutrition and Exercise Physiology (J.P.), University of Missouri, Columbia, Missouri 65211; and Departments of Child Health (65201) (J.P.) and Biological Engineering (L.A.M.-L., F.I.R.-P.), University of Missouri, Columbia, Missouri 65211
| | - Francisco I Ramirez-Perez
- Division of Endocrinology, Diabetes and Metabolism (V.G.D., G.L., G.J., A.R.A., C.M., J.R.S., D.H., D.C., B.J.B., M.G.), Department of Medicine, University of Missouri Columbia School of Medicine, Columbia, Missouri 65212; Department of Medical Pharmacology and Physiology (65212) (V.G.D., F.I.R.-P., L.A.M.-L., J.R.S.) and Research Service (V.G.D., J.R.S.), Harry S Truman Memorial Veterans Hospital, Columbia, Missouri 65201; Dalton Cardiovascular Research Center (F.I.R.-P., L.A.M.-L., J.P.), University of Missouri, Columbia, Missouri 65201; Department of Nutrition and Exercise Physiology (J.P.), University of Missouri, Columbia, Missouri 65211; and Departments of Child Health (65201) (J.P.) and Biological Engineering (L.A.M.-L., F.I.R.-P.), University of Missouri, Columbia, Missouri 65211
| | - Dominic Haertling
- Division of Endocrinology, Diabetes and Metabolism (V.G.D., G.L., G.J., A.R.A., C.M., J.R.S., D.H., D.C., B.J.B., M.G.), Department of Medicine, University of Missouri Columbia School of Medicine, Columbia, Missouri 65212; Department of Medical Pharmacology and Physiology (65212) (V.G.D., F.I.R.-P., L.A.M.-L., J.R.S.) and Research Service (V.G.D., J.R.S.), Harry S Truman Memorial Veterans Hospital, Columbia, Missouri 65201; Dalton Cardiovascular Research Center (F.I.R.-P., L.A.M.-L., J.P.), University of Missouri, Columbia, Missouri 65201; Department of Nutrition and Exercise Physiology (J.P.), University of Missouri, Columbia, Missouri 65211; and Departments of Child Health (65201) (J.P.) and Biological Engineering (L.A.M.-L., F.I.R.-P.), University of Missouri, Columbia, Missouri 65211
| | - Vincent G DeMarco
- Division of Endocrinology, Diabetes and Metabolism (V.G.D., G.L., G.J., A.R.A., C.M., J.R.S., D.H., D.C., B.J.B., M.G.), Department of Medicine, University of Missouri Columbia School of Medicine, Columbia, Missouri 65212; Department of Medical Pharmacology and Physiology (65212) (V.G.D., F.I.R.-P., L.A.M.-L., J.R.S.) and Research Service (V.G.D., J.R.S.), Harry S Truman Memorial Veterans Hospital, Columbia, Missouri 65201; Dalton Cardiovascular Research Center (F.I.R.-P., L.A.M.-L., J.P.), University of Missouri, Columbia, Missouri 65201; Department of Nutrition and Exercise Physiology (J.P.), University of Missouri, Columbia, Missouri 65211; and Departments of Child Health (65201) (J.P.) and Biological Engineering (L.A.M.-L., F.I.R.-P.), University of Missouri, Columbia, Missouri 65211
| | - Annayya R Aroor
- Division of Endocrinology, Diabetes and Metabolism (V.G.D., G.L., G.J., A.R.A., C.M., J.R.S., D.H., D.C., B.J.B., M.G.), Department of Medicine, University of Missouri Columbia School of Medicine, Columbia, Missouri 65212; Department of Medical Pharmacology and Physiology (65212) (V.G.D., F.I.R.-P., L.A.M.-L., J.R.S.) and Research Service (V.G.D., J.R.S.), Harry S Truman Memorial Veterans Hospital, Columbia, Missouri 65201; Dalton Cardiovascular Research Center (F.I.R.-P., L.A.M.-L., J.P.), University of Missouri, Columbia, Missouri 65201; Department of Nutrition and Exercise Physiology (J.P.), University of Missouri, Columbia, Missouri 65211; and Departments of Child Health (65201) (J.P.) and Biological Engineering (L.A.M.-L., F.I.R.-P.), University of Missouri, Columbia, Missouri 65211
| | - Guanghong Jia
- Division of Endocrinology, Diabetes and Metabolism (V.G.D., G.L., G.J., A.R.A., C.M., J.R.S., D.H., D.C., B.J.B., M.G.), Department of Medicine, University of Missouri Columbia School of Medicine, Columbia, Missouri 65212; Department of Medical Pharmacology and Physiology (65212) (V.G.D., F.I.R.-P., L.A.M.-L., J.R.S.) and Research Service (V.G.D., J.R.S.), Harry S Truman Memorial Veterans Hospital, Columbia, Missouri 65201; Dalton Cardiovascular Research Center (F.I.R.-P., L.A.M.-L., J.P.), University of Missouri, Columbia, Missouri 65201; Department of Nutrition and Exercise Physiology (J.P.), University of Missouri, Columbia, Missouri 65211; and Departments of Child Health (65201) (J.P.) and Biological Engineering (L.A.M.-L., F.I.R.-P.), University of Missouri, Columbia, Missouri 65211
| | - Dongqing Chen
- Division of Endocrinology, Diabetes and Metabolism (V.G.D., G.L., G.J., A.R.A., C.M., J.R.S., D.H., D.C., B.J.B., M.G.), Department of Medicine, University of Missouri Columbia School of Medicine, Columbia, Missouri 65212; Department of Medical Pharmacology and Physiology (65212) (V.G.D., F.I.R.-P., L.A.M.-L., J.R.S.) and Research Service (V.G.D., J.R.S.), Harry S Truman Memorial Veterans Hospital, Columbia, Missouri 65201; Dalton Cardiovascular Research Center (F.I.R.-P., L.A.M.-L., J.P.), University of Missouri, Columbia, Missouri 65201; Department of Nutrition and Exercise Physiology (J.P.), University of Missouri, Columbia, Missouri 65211; and Departments of Child Health (65201) (J.P.) and Biological Engineering (L.A.M.-L., F.I.R.-P.), University of Missouri, Columbia, Missouri 65211
| | - Brady J Barron
- Division of Endocrinology, Diabetes and Metabolism (V.G.D., G.L., G.J., A.R.A., C.M., J.R.S., D.H., D.C., B.J.B., M.G.), Department of Medicine, University of Missouri Columbia School of Medicine, Columbia, Missouri 65212; Department of Medical Pharmacology and Physiology (65212) (V.G.D., F.I.R.-P., L.A.M.-L., J.R.S.) and Research Service (V.G.D., J.R.S.), Harry S Truman Memorial Veterans Hospital, Columbia, Missouri 65201; Dalton Cardiovascular Research Center (F.I.R.-P., L.A.M.-L., J.P.), University of Missouri, Columbia, Missouri 65201; Department of Nutrition and Exercise Physiology (J.P.), University of Missouri, Columbia, Missouri 65211; and Departments of Child Health (65201) (J.P.) and Biological Engineering (L.A.M.-L., F.I.R.-P.), University of Missouri, Columbia, Missouri 65211
| | - Mona Garro
- Division of Endocrinology, Diabetes and Metabolism (V.G.D., G.L., G.J., A.R.A., C.M., J.R.S., D.H., D.C., B.J.B., M.G.), Department of Medicine, University of Missouri Columbia School of Medicine, Columbia, Missouri 65212; Department of Medical Pharmacology and Physiology (65212) (V.G.D., F.I.R.-P., L.A.M.-L., J.R.S.) and Research Service (V.G.D., J.R.S.), Harry S Truman Memorial Veterans Hospital, Columbia, Missouri 65201; Dalton Cardiovascular Research Center (F.I.R.-P., L.A.M.-L., J.P.), University of Missouri, Columbia, Missouri 65201; Department of Nutrition and Exercise Physiology (J.P.), University of Missouri, Columbia, Missouri 65211; and Departments of Child Health (65201) (J.P.) and Biological Engineering (L.A.M.-L., F.I.R.-P.), University of Missouri, Columbia, Missouri 65211
| | - Jaume Padilla
- Division of Endocrinology, Diabetes and Metabolism (V.G.D., G.L., G.J., A.R.A., C.M., J.R.S., D.H., D.C., B.J.B., M.G.), Department of Medicine, University of Missouri Columbia School of Medicine, Columbia, Missouri 65212; Department of Medical Pharmacology and Physiology (65212) (V.G.D., F.I.R.-P., L.A.M.-L., J.R.S.) and Research Service (V.G.D., J.R.S.), Harry S Truman Memorial Veterans Hospital, Columbia, Missouri 65201; Dalton Cardiovascular Research Center (F.I.R.-P., L.A.M.-L., J.P.), University of Missouri, Columbia, Missouri 65201; Department of Nutrition and Exercise Physiology (J.P.), University of Missouri, Columbia, Missouri 65211; and Departments of Child Health (65201) (J.P.) and Biological Engineering (L.A.M.-L., F.I.R.-P.), University of Missouri, Columbia, Missouri 65211
| | - Luis A Martinez-Lemus
- Division of Endocrinology, Diabetes and Metabolism (V.G.D., G.L., G.J., A.R.A., C.M., J.R.S., D.H., D.C., B.J.B., M.G.), Department of Medicine, University of Missouri Columbia School of Medicine, Columbia, Missouri 65212; Department of Medical Pharmacology and Physiology (65212) (V.G.D., F.I.R.-P., L.A.M.-L., J.R.S.) and Research Service (V.G.D., J.R.S.), Harry S Truman Memorial Veterans Hospital, Columbia, Missouri 65201; Dalton Cardiovascular Research Center (F.I.R.-P., L.A.M.-L., J.P.), University of Missouri, Columbia, Missouri 65201; Department of Nutrition and Exercise Physiology (J.P.), University of Missouri, Columbia, Missouri 65211; and Departments of Child Health (65201) (J.P.) and Biological Engineering (L.A.M.-L., F.I.R.-P.), University of Missouri, Columbia, Missouri 65211
| | - James R Sowers
- Division of Endocrinology, Diabetes and Metabolism (V.G.D., G.L., G.J., A.R.A., C.M., J.R.S., D.H., D.C., B.J.B., M.G.), Department of Medicine, University of Missouri Columbia School of Medicine, Columbia, Missouri 65212; Department of Medical Pharmacology and Physiology (65212) (V.G.D., F.I.R.-P., L.A.M.-L., J.R.S.) and Research Service (V.G.D., J.R.S.), Harry S Truman Memorial Veterans Hospital, Columbia, Missouri 65201; Dalton Cardiovascular Research Center (F.I.R.-P., L.A.M.-L., J.P.), University of Missouri, Columbia, Missouri 65201; Department of Nutrition and Exercise Physiology (J.P.), University of Missouri, Columbia, Missouri 65211; and Departments of Child Health (65201) (J.P.) and Biological Engineering (L.A.M.-L., F.I.R.-P.), University of Missouri, Columbia, Missouri 65211
| |
Collapse
|
8
|
Jia G, Habibi J, Aroor AR, Martinez-Lemus LA, DeMarco VG, Ramirez-Perez FI, Sun Z, Hayden MR, Meininger GA, Mueller KB, Jaffe IZ, Sowers JR. Endothelial Mineralocorticoid Receptor Mediates Diet-Induced Aortic Stiffness in Females. Circ Res 2016; 118:935-943. [PMID: 26879229 DOI: 10.1161/circresaha.115.308269] [Citation(s) in RCA: 133] [Impact Index Per Article: 16.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/30/2015] [Accepted: 02/12/2016] [Indexed: 12/13/2022]
Abstract
RATIONALE Enhanced activation of the mineralocorticoid receptors (MRs) in cardiovascular tissues increases oxidative stress, maladaptive immune responses, and inflammation with associated functional vascular abnormalities. We previously demonstrated that consumption of a Western diet (WD) for 16 weeks results in aortic stiffening, and that these abnormalities were prevented by systemic MR blockade in female mice. However, the cell-specific role of endothelial cell MR (ECMR) in these maladaptive vascular effects has not been explored. OBJECTIVE We hypothesized that specific deletion of the ECMR would prevent WD-induced increases in endothelial sodium channel activation, reductions in bioavailable nitric oxide, increased vascular remodeling, and associated increases in vascular stiffness in females. METHODS AND RESULTS Four-week-old female ECMR knockout and wild-type mice were fed either mouse chow or WD for 16 weeks. WD feeding resulted in aortic stiffness and endothelial dysfunction as determined in vivo by pulse wave velocity and ex vivo by atomic force microscopy, and wire and pressure myography. The WD-induced aortic stiffness was associated with enhanced endothelial sodium channel activation, attenuated endothelial nitric oxide synthase activation, increased oxidative stress, a proinflammatory immune response and fibrosis. Conversely, cell-specific ECMR deficiency prevented WD-induced aortic fibrosis and stiffness in conjunction with reductions in endothelial sodium channel activation, oxidative stress and macrophage proinflammatory polarization, restoration of endothelial nitric oxide synthase activation. CONCLUSIONS Increased ECMR signaling associated with consumption of a WD plays a key role in endothelial sodium channel activation, reduced nitric oxide production, oxidative stress, and inflammation that lead to aortic remodeling and stiffness in female mice.
Collapse
Affiliation(s)
- Guanghong Jia
- Diabetes and Cardiovascular Research Center, University of Missouri School of Medicine, Columbia, MO, 65212, USA.,Research Service, Harry S Truman Memorial Veterans Hospital, Research Service, 800 Hospital Dr, Columbia, MO, 65201, USA
| | - Javad Habibi
- Diabetes and Cardiovascular Research Center, University of Missouri School of Medicine, Columbia, MO, 65212, USA.,Research Service, Harry S Truman Memorial Veterans Hospital, Research Service, 800 Hospital Dr, Columbia, MO, 65201, USA
| | - Annayya R Aroor
- Diabetes and Cardiovascular Research Center, University of Missouri School of Medicine, Columbia, MO, 65212, USA.,Research Service, Harry S Truman Memorial Veterans Hospital, Research Service, 800 Hospital Dr, Columbia, MO, 65201, USA
| | - Luis A Martinez-Lemus
- Research Service, Harry S Truman Memorial Veterans Hospital, Research Service, 800 Hospital Dr, Columbia, MO, 65201, USA.,Department of Medical Pharmacology and Physiology, University of Missouri School of Medicine, Columbia, MO, 65212, USA.,Dalton Cardiovascular Research Center, University of Missouri, Columbia, MO, 65212, USA
| | - Vincent G DeMarco
- Diabetes and Cardiovascular Research Center, University of Missouri School of Medicine, Columbia, MO, 65212, USA.,Research Service, Harry S Truman Memorial Veterans Hospital, Research Service, 800 Hospital Dr, Columbia, MO, 65201, USA.,Department of Medical Pharmacology and Physiology, University of Missouri School of Medicine, Columbia, MO, 65212, USA
| | | | - Zhe Sun
- Dalton Cardiovascular Research Center, University of Missouri, Columbia, MO, 65212, USA
| | - Melvin R Hayden
- Diabetes and Cardiovascular Research Center, University of Missouri School of Medicine, Columbia, MO, 65212, USA.,Research Service, Harry S Truman Memorial Veterans Hospital, Research Service, 800 Hospital Dr, Columbia, MO, 65201, USA
| | - Gerald A Meininger
- Department of Medical Pharmacology and Physiology, University of Missouri School of Medicine, Columbia, MO, 65212, USA.,Dalton Cardiovascular Research Center, University of Missouri, Columbia, MO, 65212, USA
| | | | - Iris Z Jaffe
- Molecular Cardiology Research Institute, Tufts Medical Center, Boston, MA 02111, USA
| | - James R Sowers
- Diabetes and Cardiovascular Research Center, University of Missouri School of Medicine, Columbia, MO, 65212, USA.,Research Service, Harry S Truman Memorial Veterans Hospital, Research Service, 800 Hospital Dr, Columbia, MO, 65201, USA.,Department of Medical Pharmacology and Physiology, University of Missouri School of Medicine, Columbia, MO, 65212, USA.,Dalton Cardiovascular Research Center, University of Missouri, Columbia, MO, 65212, USA
| |
Collapse
|